Brett A. Giffin
Chief Commercial OfficerMr. Brett Giffin serves as Chief Commercial Officer at T2 Biosystems, Inc. since November 8, 2021. Mr. Giffin has a wealth of industry experience and commercial leadership to T2 Biosystems, having served as Chief Executive Officer for two early stage medical technology companies, as Chief Commercial Officer at Accriva Diagnostics (formerly ITC Medical) and in several sales and marketing leadership roles at Datascope, Covidien, Boston Scientific and Johnson & Johnson. From September 2017 to April 2019, Mr. Giffin was the Chief Executive Officer of Fibronostics. From June 2015 to September 2017, Mr. Giffin was the Chief Executive Officer and President of 3SI Systems, LLC. He began his career as a U.S. Army officer, serving in Panama and Central America. Prior to joining the company, Mr. Giffin served as a Managing Director for Mancini Burfield Edgerton, a retained executive search and management consulting firm focused on life sciences from April 2019 until November 2021. Mr. Giffin is a Distinguished Military Graduate of the College of William & Mary and received a bachelor’s degree in Political Science from Christopher Newport University and a Masters' in Business Management from the University of Phoenix.
Positions
- Company NameT2 Biosystems, Inc.Stock CodeTTOOPositionChief Commercial OfficerColleagues
- CRCraig R. JalbertCEO, President, Corporate Treasurer, Corporate Secretary & Director
- KJKelley J. MorganChief People Officer
- RSRoger SmithSenior Vice President of Science Research & Development
- PGPeter G. PappasMember of Clinical Advisory Board
- ESEric S. RosenbergMember of Clinical Advisory Board
- LBLouis B. RiceMember of Clinical Advisory Board
- MAMichael A. PfallerMember of Clinical Advisory Board
